Future Science Group

Eric Bonner (Eurofins) discusses the techniques he uses for assessing immunogenicity, key challenges and what the future may hold for the field in this podcast, exclusive to the Bioanalysis Zone Spotlight on immunogenicity. You can find many more resources on immunogenicity via the immunogenicity Spotlight pages on Bioanalysis Zone: http://bit.ly/2J6w15F

Georgi Makin, Editor of 3DMedNet, is joined by Jade Parker (Oncology Central) and Shana Cook (Milwaukee School of Engineering) as they discuss how patient experience with surgery can be improved with 3D printing, drawing from Shana’s personal experience 3D printing her own tumor from MRI data, following surgical resection of retroperitoneal leiomyosarcoma. Note: > At 5:11, Cook left Benedictine University in May of 2013, rather than March as quoted. > At 5:43, the MRI scan revealing the tumor was conducted in 2015, rather than 2013 as quoted. Find out more: Georgi Makin is the Editor of 3DMedNet (www.3dmednet.com), a community website that unites the diverse and multifaceted world of medical 3D printing with the aim of advancing the field, together. Jade Parker is the Senior Editor of Oncology Central (www.oncology-central.com), a free online platform that unites all aspects of oncology to support a multidisciplinary approach to progression of the field. Shana Cook is a Biomedical Engineering Student

Find out more about the role of exosomes in flow cytometry studies in this interview Joyce Slusser (KCAS; KS, USA).

Find out more about current challenges and recent developments in seen in the field of flow cytometry in this interview with Clara Brando and Ted Baginski (Eurofins; MO, USA).

In this podcast, Hugh Davis (Frontage Laboratories; PA, USA) discusses the challenges associated with gene therapy and what the future may hold for the field.

Abigail Sawyer and Tristan Free from the BioTechniques editorial team talk to Assistant Editor, Jenny Straiton about her recent Tech news piece on Cerebral Organoids and the history of neuroscience.

Find out more about the challenges associated with CAR-T cell immunotherapies and what the future may hold for the field in this interview with Marco Ruella.

Abigail Sawyer and Tristan Free from the BioTechniques editorial team discuss the recently published tech news piece on unsustainability in the lab and the ways that some institutions are trying to address it.

Fake news, the reproducibility crisis and politics are all reasons why the public may distrust science. We spoke to Gareth Mitchell, host on the BBC World Service radio show Click and lecturer in Imperial College London's science communication department, to find out a little bit more about science communication.

In this interview Paul Wyatt, University of Dundee (Scotland) describes the work taking place at the Wellcome Center for Anti-Infectives Research into neglected tropical diseases.

Find out more about working with immunogenicity as well as what the future may hold for the field in this interview with Joyce Slusser (KCAS) - http://bit.ly/2OjaOX7

We spoke to Mark Behlke, the chief scientific officer of Integrated DNA Technologies (IA, USA), about the current limitations of CRISPR/Cas9 techniques and the potential of the novel HiFI Cas9 enzyme to resolve these limitations, as shown in a sickle cell disease-causing mutation.

In line with our October focus on healthcare-associated infections, we spoke to Amy Mathers about her research on the role of hospital plumbing in the evolution and exchange of genes of drug resistance. Amy discussed her research on sink traps, toilets and wastewater, what solutions hospitals can use and antibiotic resistance in the broader context – including the role of infection prevention and control.

Find out more about the flow cytometry in this Bioanalysis Zone interview with Christoph Eberle (Charles River Laboratories), as part of our 'In the Zone' feature. You can find out more about flow cytometry on the website, at: http://bit.ly/2RuwAKi

In this podcast, Roshaine Wijayatunga, Senior Editor for Oncology at Future Science Group speaks with Barbara Moss, a Patient Ambassador for Europacolon (UK) and Bowel Cancer UK. At the age of 52, in 2006, Barbara was diagnosed with Stage IV colorectal cancer of the colon, spread to the liver, and was told she had 3–5 months to live. Barbara is now an active campaigner and an active member of several organizations in the UK and Europe. Her main wish is for patients to be able to access the medicine that they need, to have choices clearly explained and to be treated personally.

Since Zika broke into the news in 2016, new research has been uncovering more information about this virus – we spoke to Dustin Farr at the recent ASM Microbe meeting where he was presenting a poster on Zika infection in corneal cells.

Find out more about the technologies utilized in drug discovery and what the future holds for biotherapeutic drug metabolism studies in this Bioanalysis Zone interview with Kevin Ray (MilliporeSigma), as part of our 'In the Zone' feature on drug metabolism. You can find out more about drug metabolism on the website, at: https://www.bioanalysis-zone.com/2018/08/13/in-the-zone_inz_drug_metabolism/ The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.

As part of our focus, we present this podcast where we talk to Mark Savage (Biotransformation and ADME Scientist, Unilabs, UK). Mark introduces what biotransformation is and the technologies used to characterize biotransformation. He discusses how software tools can address certain challenges and bring forward compounds from discovery to development.

At the FENS Forum of Neuroscience (7–11 July, Berlin, Germany), we had the pleasure of speaking with Irene Tracey, who is a Professor based at the University of Oxford (UK). Irene is also the Head of the Nuffield Department of Clinical Neurosciences (Oxford, UK), which includes a multidisciplinary taskforce working to understand neuroscience from a basic discovery perspective all the way through to clinical problems. Irene’s research particularly focuses on using neuroimaging to understand pain. In this NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks to Irene to find out more about her talk at FENS, including significant breakthroughs within the field and if we could ever have one standardized measure of pain. View more podcasts, news and exclusive interviews at www.neuro-central.com

The TAILORx study demonstrated that most women with a specific early-stage breast cancer and midrange score on the Oncotype Dx test do not need chemotherapy after surgery. These findings will spare thousands of women from the harmful effects of chemotherapy. We spoke with Andrew Paramore from Genomic Health (CA, USA)to discover insider details of the trial and what’s next for TAILORx.